PTCT - PTCセラピュ―ティクス (PTC Therapeutics Inc.)

PTCTのニュース

   PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals  2020/06/01 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., June 1, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage…
   PTC Therapeutics Announces New Leadership Appointments  2020/04/17 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., April 17, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein, M.D., to Chief Development Officer and Eric Pauwels to Chief Business Officer. Dr. Klein will be responsible for the development of our clinical…
   Partick Thistle Charitable Trust providing over 100 meals a day from Firhill  2020/04/02 14:35:31 Glasgow Times
THE Partick Thistle Charitable Trust (PTCT) has been providing over 100 meals a day from the Maryhill club's stadium to support the local community…
   PTC Therapeutics EPS misses by $0.88, beats on revenue  2020/03/02 21:09:51 Seeking Alpha
PTC Therapeutics (NASDAQ:PTCT): Q4 GAAP EPS of -$1.37 misses by $0.88. Revenue of $96.45M (+11.7% Y/Y) beats by $1.52M. Cash and cash equivalents of $686.6
   The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study  2020/02/20 12:06:25 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.
   PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals  2020/06/01 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., June 1, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage…
   PTC Therapeutics Announces New Leadership Appointments  2020/04/17 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., April 17, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein, M.D., to Chief Development Officer and Eric Pauwels to Chief Business Officer. Dr. Klein will be responsible for the development of our clinical…
   Partick Thistle Charitable Trust providing over 100 meals a day from Firhill  2020/04/02 14:35:31 Glasgow Times
THE Partick Thistle Charitable Trust (PTCT) has been providing over 100 meals a day from the Maryhill club's stadium to support the local community…
   PTC Therapeutics EPS misses by $0.88, beats on revenue  2020/03/02 21:09:51 Seeking Alpha
PTC Therapeutics (NASDAQ:PTCT): Q4 GAAP EPS of -$1.37 misses by $0.88. Revenue of $96.45M (+11.7% Y/Y) beats by $1.52M. Cash and cash equivalents of $686.6
   The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study  2020/02/20 12:06:25 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.
   PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals  2020/06/01 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., June 1, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage…
   PTC Therapeutics Announces New Leadership Appointments  2020/04/17 12:00:00 PR Newswire
SOUTH PLAINFIELD, N.J., April 17, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein, M.D., to Chief Development Officer and Eric Pauwels to Chief Business Officer. Dr. Klein will be responsible for the development of our clinical…
   Partick Thistle Charitable Trust providing over 100 meals a day from Firhill  2020/04/02 14:35:31 Glasgow Times
THE Partick Thistle Charitable Trust (PTCT) has been providing over 100 meals a day from the Maryhill club's stadium to support the local community…
   PTC Therapeutics EPS misses by $0.88, beats on revenue  2020/03/02 21:09:51 Seeking Alpha
PTC Therapeutics (NASDAQ:PTCT): Q4 GAAP EPS of -$1.37 misses by $0.88. Revenue of $96.45M (+11.7% Y/Y) beats by $1.52M. Cash and cash equivalents of $686.6
   The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study  2020/02/20 12:06:25 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.

calendar